Table 2 Univariate and multivariate association of relevant patient characteristics with the outcome: absence of DAS28 remission at 12 months

DAS28 per point

1.34 (1.03–1.73)

0.03

1.60 (1.18–2.2)

0.002

Female gender

1.94 (0.96–3.3.9)

0.06

1.93 (0.91–4)

0.09

RF positive

1.78 (0.87–3.63)

0.11

2.34 (1.07–5.1)

0.03

aCCP positive

1.54 (0.79–3)

0.21

RF and aCCP positive

1.59 (0.83–3)

0.17

Age per year

1.01 (0.99–1.04)

0.24

 Sub-cohort A

Reference

NA

Reference

NA

 Sub-cohort B

0.49 (0.13–1.73)

0.27

0.20 (0.05–0.85)

0.03

 Sub-cohort C

1.26 (0.47–3.39)

0.64

0.68 (0.20–2.4)

0.55

 Sub-cohort D

1.26 (0.26–1.48)

0.28

0.85 (0.30–2.4)

0.76

Symptom duration (months)

1.0 (0.91–1.1)

0.99

SvH per point

1.04 (0.93–1.15)

0.48

Smoking yes/no

1.56 (0.73–3.4)

0.25

HAQ per point

1.16 (0.71–1.9)

0.55

USJC per point

0.99 (0.92–1.06)

0.77

0.96 (0.89–1.04)

0.31